Earnings Feed
Start Free
GeneDx Holdings Corp.·4

Jun 23, 4:25 PM ET

Casdin Eli 4

Research Summary

AI-generated summary

Updated

GeneDx (WGS) 10% Owner Eli Casdin Exercises Options and Receives RSUs

What Happened
Eli Casdin, reported as a 10% owner (via affiliated funds and entities), reported on June 18, 2026 that he (or entities he controls) exercised/converted 3,576 derivative shares and received a grant of 4,248 restricted stock units (RSUs). All reported items show $0.00 per share (no cash consideration). The exercise/conversion of 3,576 shares was also reported as a disposition on the same date.

Key Details

  • Transaction date: 2026-06-18 (Form filed 2026-06-23 — filed one business day late).
  • Transactions reported:
    • Exercise/conversion (code M): 3,576 shares acquired @ $0.00
    • Grant/award (code A): 4,248 RSUs acquired @ $0.00 (derivative)
    • Exercise/conversion (code M): 3,576 shares disposed @ $0.00 (derivative)
  • Consideration: All items reported at $0.00 (per footnote F1 RSUs settle for no consideration).
  • Shares owned after transaction: Not specified on the supplied report.
  • Ownership structure: Securities are held by affiliated entities (Casdin Partners Master Fund, GP entities, CMLS Holdings); Casdin is the managing member and disclaims direct beneficial ownership except to the extent of pecuniary interest (see F2–F4).
  • Vesting notes: Footnotes indicate RSU vesting schedules — one award vests by the earlier of the 2026 annual meeting or first anniversary (F6); another vests by the earlier of the 2027 annual meeting or first anniversary (F5).
  • Filing timeliness: Report was filed 2026-06-23 for a 2026-06-18 transaction (appears late by one business day).

Context

  • Derivative/RSU explanation: RSUs are contingent rights to receive shares upon settlement for no cash (F1). "Exercise/conversion" entries indicate conversion of derivative securities into or for shares; the back-to-back acquisition and disposition of 3,576 shares suggests a conversion/transfer event rather than a typical open-market sale.
  • Investor note: This filing reflects institutional/affiliate activity by a reported 10% owner and related entities, not a routine executive open-market buy/sell. As always, filings are factual disclosures and do not by themselves indicate the reporting person’s intent or view of the company.